Merck mulls some settlements?
In some narrow circumstances drug giant might break
from Vioxx no-settle stance.
NEW YORK (Reuters) - U.S. drug company Merck &
Co. might consider settling a small number of Vioxx
cases involving people who claim they were harmed by
the painkiller and who fit a very narrow profile, the
Wall Street Journal reported on Friday.
The company's general counsel stressed that Merck
had not changed its strategy of fighting every case in
court, it said.
However, a Merck spokeswoman told the newspaper
that in cases where patients took Vioxx for more than
18 months and had no other risk factors for heart
attacks or strokes, "we're going to have to
carefully look at those cases."
The statement suggests for the first time that
settlement of a small number of Vioxx cases may be
part of Merck's plan, the Journal said. The exact
number of people meeting the criteria is not clear.
Read Entire Article
<< Back to
Vioxx News
Email this Page |
Print this Page
|
